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Abstract 
Background. Many mathematical models characterizing mechanisms of cell fate decisions 
have been constructed recently. Their further study may be impossible without development 
of methods of model composition, which is complicated by the fact that several models 
describing the same processes could use different reaction chains or incomparable sets of 
parameters. Detailed models not supported by sufficient volume of experimental data suffer 
from non-unique choice of parameter values, non-reproducible results, and difficulty of 
analysis. Thus, it is necessary to reduce existing models to identify key elements determining 
their dynamics, and it is also required to design the methods allowing us to combine them. 
Results. Here we propose a new approach to model composition, based on reducing several 
models to the same level of complexity and subsequent combining them together. Firstly, we 
suggest a set of model reduction tools that can be systematically applied to a given model. 
Secondly, we suggest a notion of a minimal complexity model. This model is the simplest 
one that can be obtained from the original model using these tools and still able to 
approximate experimental data. Thirdly, we propose a strategy for composing the reduced 
models together. Connection with the detailed model is preserved, which can be 
advantageous in some applications. A toolbox for model reduction and composition has been 
implemented as part of the BioUML software and tested on the example of integrating two 
previously published models of the CD95 (APO-1/Fas) signaling pathways. We show that the 
reduced models lead to the same dynamical behavior of observable species and the same 
predictions as in the precursor models. The composite model is able to recapitulate several 
experimental datasets which were used by the authors of the original models to calibrate them 
separately, but also has new dynamical properties. 
Conclusion. Model complexity should be comparable to the complexity of the data used to 
train the model. Systematic application of model reduction methods allows implementing this 
modeling principle and finding models of minimal complexity compatible with the data. 
Combining such models is much easier than of precursor models and leads to new model 
properties and predictions. 
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Background 
Systems biology aims to study complex interactions in living systems and focuses on analysis 
and modeling their properties. Mathematical modeling provides several ways to describe 
biological processes based on experimental information of different kind. However, creation 
of detailed models not supported by enough experimental data often makes their analysis and 
interpretation difficult [1]. Several aspects of the same process can be modeled using 
different levels of abstraction involving different reaction chains, chemical kinetics, and 
incomparable sets of parameters. Such models are difficult to merge. Meanwhile, merging is 
an important approach for creation of complex models. Thus, development of efficient 
methods and software, allowing us to combine models, is the object of intense study in 
systems biology. In our work, we focused on the fact that, generally, complexity of models is 
not comparable to the volume of experimental data used to adjust their parameters. Due to 
this fact, we turn to the methods of model reduction allowing us to minimize model’s 
complexity without affecting the model simulation dynamics. 
Model reduction is a well-established technique in many fields of biochemical research 
and engineering. It has been used for many years in chemical kinetics (for reviews, see [2-4]) 
and has already found multiple applications in systems biology, including discrete modeling 
[5] and modeling of metabolic pathways [6, 7]. The principles of this technique have been 
applied in computational biology [8] and implemented as a part of widely used pathway 
simulators such as BioUML [9], BIOCHAM [10], COPASI [11], and GINsim [12]. Model 
reduction led to new insights in mechanisms of translation regulation by microRNAs [13, 14] 
and was applied for analysis of such signaling pathways as JAK-STAT [15], NF-κB [16], and 
EGFR [17]. 
In our investigation, we used the principles of model reduction to construct reasonably 
accurate minimal size approximations of two different models describing the CD95 signaling 
pathways [18, 19]. The first model explores pro-apoptotic properties of CD95 after 
stimulation by its natural ligand CD95L or by agonistic antibodies anti-CD95 implying 
formation of the death-inducing signaling complex (DISC) [18, 20]. DISC consists of 
oligomerized CD95, death domain-containing adaptor FAS-associated molecule (FADD), 
procaspases-8 and -10, and two isoforms of cellular FLIP (CFLAR) protein (cFLIP long and 
cFLIP short). Caspase-8 leads to activation of effector caspase-3 directly (type I cells) or via 
stimulation of cytochrome C release from the mitochondria (type II cells) [21]. The latter step 
requires formation of the apoptosome complex and activation of caspase-9. Once activated, 
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caspase-3 cleaves poly(ADP-ribose) polymerase (PARP), thereby making the apoptotic 
process irreversible. The second model describes the state when CD95 not only activates the 
pro-apoptotic pathway, but also induces transcription factor NF-κB that is an important 
regulator of cell survival functioning [19]. This is possible due to cFLIPL cleavage in the 
DISC complex. The cleaved p43-FLIP directly interacts with the IKK complex and activates 
it. The activated IKK performs phosphorylation of the IκB protein and thereby frees NF-κB. 
The authors of the models have evaluated concentration changes of major apoptotic 
molecules by Western blot analysis and represented them as relative values at given time 
points. Using the systematic methodology [2] implemented in the BioUML software, we 
reduced the models so that they still satisfy these data. This allowed us to simplify the 
overlapping components of the models and find a way for their composition. 
Methods 
Model reduction 
Mathematical modeling of biological processes based on the classical theory of chemical 
kinetics assumes that a model consists of a set of species   (       ) associated with a 
set of variables  ( )  (  ( )     ( )) depending on time   [   ],    
 , and 
representing their concentrations, and a set of biochemical reactions with rates  ( )  
(  ( )     ( )) depending on a set of kinetic constants  . Reaction rates are modeled by 
mass-action or Michaelis-Menten kinetics. A system of ordinary differential equations (ODE) 
representing a linear combination of reaction rates is used to describe the model behavior 
over time: 
  ( )
  
    (     )  ( )      (1) 
Here   is a stoichiometric matrix of   by  . We say that     is a steady state of the system 
(1) if 
   (       )       
   
  ( )    
    (2) 
Model reduction implies transformation of the ODE system to another one with smaller 
number of equations without affecting dynamics of variables   ( )     ( ), which is fixed 
by a set of experimental points   
   (   ) at given times    ,         , where    is number 
of such points for the concentration   ( ),        . To check dynamics preservation in the 
course of model reduction, we consider the function of deviations defined as a normalized 
sum of squared differences [11]: 
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where            , weights    √  
   ∑ (  
   (   ))
 
  are calculated as mean 
squared values of experimental concentrations for each variable and the normalizing factor 
        is used to make all concentration trajectories to have similar importance. 
Reducing kinetic model is possible when some quantities are much smaller than other 
quantities and can be neglected. Usually, this implies some qualitative relations (much 
bigger, much smaller) between model parameters. When these relations satisfy certain rules, 
we can approximate the detailed model by a simpler one. If the parameters are 
(approximately) determined, as in our case, we find an approximation specific for a region of 
the parameter space. However, if we want to investigate the model behavior for the entire 
space, we need to decompose it into regions characterized by asymptotically different 
behaviors of the dynamical systems. Afterwards, a specific reduction should be performed for 
each region (fig. 1). 
We define the minimal complexity model as a reduced model with the minimal number of 
elements (species and reactions) so that the deviation function value (3) calculated for the 
reduced model is different from the original model no more than 20%. Such threshold is 
explained by the fact that in this work we considered experimental data obtained by Bentele 
et al. [18] and Neumann et al. [19] using Western blot technology with the standard deviation 
15-20%. 
Reduction of mathematical model complexity is achievable by different methods [2]. 
Description of the methods used in our work is provided below. 
(MR1) Removal of slow reactions. In the simplest case, one can remove a reaction which 
rate does not change significantly the amount of any species, during the duration T of the 
computational simulation (i.e., its rate v normalized on the characteristic amount of any 
reactant or product involved in it is much less than 1/T). In more complex case, sometimes it 
is possible to neglect slow reactions whose effect is dominated by faster reactions. We say 
that the reaction    with rate    ( ) is much slower than the reaction    with rate    ( )  if 
    |   ( )|        |   ( )| during the simulation period T (0  t  T), where     
  . 
If a chemical species is a reactant in two reactions    and   , and    is much slower than   , 
then one can test the effect of removal of   , and eliminate it in some cases, if its removal 
does not significantly change the model dynamics. Note that it is not always possible due to 
existence of slowly relaxing cyclic subsystems of faster reactions, see [2]. Also note that in 
some cases, it is sufficient to consider        or even k = 1. 
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Figure 1 – Schematic representation of the model reduction techniques 
A model consisting of four species ( ,  ,  , and  ) and two reactions (   and   ) was 
reduced taking into account the relations between time-dependent concentrations   ( ) and 
  ( ), as well as reaction rates    ( ) and    ( ). In the case when   ( )    ( ), the 
concentration of   can be considered constant for some period of time. The same 
simplification could be applied to B.  
 
 
 (MR2) Quasi-steady-state (QSS) approximation [2, 16] assumes that the variables  ( ) of 
the model can be split in two groups: “slow” basic components   ( ) and fast intermediates 
  ( ). The amounts of fast intermediates are assumed to be smaller than the amounts of basic 
components, while the reaction rates are of the same order, or both fast intermediates and 
slow components participate in the same reactions. In this situation, one can rescale the 
intermediate amounts, introducing new variables  ̃ ( )  
 
 
  ( ), where  is a small number 
such that  ̃  and    are of the same order now. For the new variables one can write 
   ( )
  
   (    ̃   )  
  ̃ ( )
  
 
 
 
   (    ̃   )  
where   and   are functions that can be obtained from (1), having values and derivatives 
of the same order of magnitude during the simulation period and for the given set of 
parameters K. If this is the case then in the limit →  one can substitute differential 
equations for  ̃  by algebraic equations   (    ̃     )   , find dependencies  ̃  
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 ̃ (    ) and exclude  ̃  from the remaining model equations. Classical example of 
application of QSS is the derivation of Michaelis-Menten formula for enzymatic catalysis 
reaction            , for the case when the amount of enzyme E is much smaller 
than the amount of the substrate S, while both S and E participate in the same reaction of 
complex S:E formation [22]. 
(MR3) Lumping analysis refers to reducing the number of model variables by grouping 
some species. In particular, this can be illustrated by reactions 
                        (4) 
with kinetic rates    ( )       ( )     ( ) and    ( )       ( )     ( ). If       and 
   ( )     ( ), then the system (4) can be replaced by a single reaction 
         
where   ( )     ( )     ( ),   ( )     ( )     ( ) and        . Note, that in this 
example lumped variables    ( ),    ( ) and    ( ),    ( ) are linearly dependent: however, 
this is not required in general case. For conditions on lumpability in monomolecular reaction 
networks, see [23]. 
(MR4) Removal of approximately linearly dependent variables s. If variables  ( ) and 
 ( ) (species concentrations or reaction rates of the model) are approximately linearly 
dependent: 
 ( )     ( )   [   ]          
then we can replace one of them by another in all kinetic laws of the model. Note that this can 
be considered as a particular case of lumping. 
(MR5) Simplification of the Michaelis-Menten kinetics. Consider a reaction   of the form 
  –   , where an enzyme   converts a substrate   into product  . Reaction rate of such 
reaction is frequently defined by the Michaelis-Menten formula 
  ( )  
    ( )    ( )
     ( )
 (5) 
where the enzyme concentration is a dynamic variable allowing to use the same kinetics in 
different regions of the phase space. If      ( ), then we can reduce this formula to the 
form:   ( )  
    ( )   ( )
  
. On the other hand, if   ( )    , then (5) can be replaced by the 
equation   ( )      ( ). 
(MR6) Simplification of equations based on the law of mass action when one reactant 
dominates others. Consider a reaction   of the form         with the kinetic law 
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  ( )       ( )     ( )  (6) 
When    ( )     ( ) for   [   ], the formula (6) can be replaced by the linear equation 
  ( )       ( )     ( ). The time   of validity of such pseudo-lineary approximation is 
defined as a period during which the relative change of    ( ) does not exceed some  , i.e. 
 ∫    ( )    
 
 
. 
One way to perform the model reduction is to apply the foregoing methods in the 
numerical order (fig.2). Note that the methods MR5 and MR6 are of the same type, so it does 
not matter which one to use first. This way assumes that we calculate the value of the 
distance function (3) at each reduction step to test whether approximation of the experimental 
data is still within allowable limit or not. 
Model analysis and comparison 
Model comparison using Akaike information criterion (   ). This criterion [24] defines the 
relative complexity of a model based on the goodness of experimental data fit and the number 
of model parameters | | (initial concentrations of species are not considered): 
         | |  (7) 
The function    is defined by the formula (3) with weights     
 ⁄  (instead of       ⁄ ) [15], 
where mean deviations     of experimental values   
   (   ) are calculated using smoothing 
spline [25]: 
   
  
 
 
∑ (  (      )    
   (      ))
 
 
    
  
For       and        we assumed   (      )    
   (      )   . 
Models can be compared using the Akaike criterion, if they approximate the same 
experimental data. When the     value of one model is less than of others, we say that this 
model is simpler in terms of this criterion. 
Model comparison with the mean    . When we want to compare models approximating 
different sets of experimental data, we could calculate the mean     coefficients by the 
formula 
        
   
    
 (8) 
where      determines the number of experimental points. 
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Steady-state analysis finds values of species concentrations according to the rules (2). It is 
desirable to reduce a model so that steady-state concentrations of all experimentally measured 
chemical species have not changed significantly. 
 
 
 
Figure 2 – Flow chart of the model reduction 
The methods of model reduction are presented in the order of their application. The last two 
methods are of the same type, so this is a choice of the systems biologist which one to use 
first. 
 
 
Sensitivity analysis reveals steady-state concentrations response to parameter 
perturbations. The local sensitivities   
  ,        , for all parameters   ,       | |, are 
calculated via finite difference approximations: 
    
   
  
   
 
  
  (      )    
  (  )
   
 
It is useful to compute the mean log sensitivity for all fitted species: 
      
∑   |   |   
    
                         (9) 
where    is the number of all parameters | | or the number of parameters retained after the 
model reduction. 
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Modular modeling 
Considering the mathematical models of CD95 signaling pathways [18, 19], we decomposed 
them into functional modules. This step allowed us to identify overlapping components of the 
models and simplify their analysis. We defined a module as a submodel (including several 
species, reactions and parameters of the model) with input, output and contact ports. The first 
two types of ports characterized variables calculated in one module and passed to another 
through a directed connection. The contact ports declared common variables of modules via 
undirected connections (for more details of modular modeling, see [26]). 
Results 
Preliminary analysis, problems and inconsistencies in the precursor models 
The mathematical model by Bentele et al. (fig. 3A) consists of 43 species including a virtual 
variable     intended for quantification of “apoptotic activity” caused by active caspases-3, -
6 and -7 and calculated by the formula 
    
  
 
(     )  (                                        )
         (     )
          (10) 
where                        . The variable     specifies a process of degradation in the 
model introduced as an exponential decay function      (   ). This function is defined by 
the formula       
      with          for all active caspases and complexes 
containing their cleaved products, and by the formula       
  for all other molecules besides 
cPARP (cleaved PARP), where      (   ) is constant. All species in the model are degraded 
with the exception of cytochrome C and Smac stored in the mitochondria, whose 
concentrations are constant. 
In total, the model contains 80 reactions (Table 1) including 24 reactions based on mass 
action kinetics, 12 reactions taken with kinetics of Michaelis-Menten, 41 reactions of 
degradation, the reaction of     production specified above and two reactions of cytochrome 
C and Smac release from the mitochondria modeled using a discrete event. The latter implies 
complete cytochrome C and Smac release within 7 minutes as soon as tBid reaches a certain 
level in comparison to Bcl-2/Bcl-XL. Since the authors did not provide exact form of the 
release function, we proposed the sigmoid function which has the expected behavior: 
        ( )    
 
     (       (                        ))
 (11) 
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where          is the time when tBid concentration reaches a value of Bcl-2/Bcl-XL,          
is the start time of release and        is the contraction coefficient. 
The model comprises 43 species (including    ) and 45 kinetic parameters, which the 
authors estimated based on the experimental data obtained by Western blot analysis for the 
human cell line SKW 6.4. Cells were stimulated by 5 μg/ml and 200 ng/ml of anti-CD95 (fast 
and reduced activation scenarios, respectively) and dynamics of several proteins (Bid, tBid, 
PARP, cPARP, procaspases-2, -3, -7, -8, -9, cleaved product of procaspase-8 p43/p41, and 
caspases-8) were measured. 
We could not reproduce the dynamics of the original model using the parameter values 
provided by the authors. In particular, there was too rapid consumption of procaspases-2, -3, -
7, -8 in the case of 5 μg/ml of anti-CD95 and procaspases-2, -9 in the case of 200 ng/ml. 
Degradation rates of procaspase-8 and caspases-8 was insufficient for both activation 
scenarios. Thus, we had to make several modifications of the original model to obtain the 
same dynamics as described in the original paper. Namely, we multiplied the rate constants of 
all the bimolecular reactions by the value 5∙10-5 and specified    equal to 3.56 min
-1
 and 0.62 
min
-1
 (instead of 0.891 min
-1
 and 0.184 min
-1
) for fast and reduced activation scenarios, 
respectively. 
The model by Neumann et al. includes 23 species, 23 reactions constructed according to the 
law of mass action, and 17 kinetic parameters (fig. 4A). It reproduces experimental 
measurements of 8 entities (total amount of procaspase-8, its cleaved product p43/p41, 
caspase-8, procaspase-3, caspase-3, IκB-α, phosphorylated IκB-α and cleaved p43-FLIP) 
obtained using Western blot technology for HeLa cells stably overexpressing CD95–GFP and 
treated with three different concentrations of agonistic anti-CD95 antibodies (1500, 500 and 
250 ng/ml). This is the reduced model suggested by the authors for description of the CD95-
mediated pathways of cell death and NF-κB activation. Model reduction was based on 
intuition about what is important in the biochemical mechanisms. It was performed as long as 
the parameter estimation procedure (repeated after each step of the reduction) was able to 
provide a good fit of the experimental data. Particularly, the details of some complex 
formations were omitted as well as some non-measured species were removed. The authors 
submitted the model to the BioModels database [27]. Thus, we had no problems reproducing 
it. 
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Figure 3 – The model by Bentele et al. and results of its reduction 
A. The original model decomposed into modules according to three steps of apoptosis: 
activation of caspases-8 and -9 and inactivation of PARP. The species retained after the 
model reduction are colored. B. The modular view of the model. The dashed connections 
were deleted during the model reduction. C. The minimal reduced model. D. The graphical 
notation used for representation of the models A-C. 
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Reduction of the CD95-signaling model 
We started the Bentele’s model reduction by excluding the direct dependence of the virtual 
species     on caspases-6 and -7. For this purpose, we approximated the amount of caspases-
7 by the linear function of caspase-3 concentration: 
                 (12) 
where        for both activation scenarios. In addition, we considered inequalities holding 
for the parameters in the formula (10): 
                                          
                
and simplified it: 
    
  
 
(                 )
        
 (     )                  (13) 
After that we decomposed the model into modules (fig. 3B) corresponding to three 
biological steps: activation of caspase-8, cytochrome C-induced activation of caspase-9 and 
PARP cleavage down-regulated by these caspases. 
Below we provide detailed description of the reduction process of all modules. The 
process is based on the flow chart represented in the figure 2. If it is enough for a reader to 
have a general idea of model reduction without going into full details, we suggest to go 
directly to the last two paragraphs of this section, where you find the summary of the model 
reduction procedure.  
Caspase-8 activation module includes 20 species and 14 reactions (besides the reactions of 
degradation), which could be divided into three groups: cleavage of procaspase-8 at the DISC 
complex, its activation triggered by caspase-3, and inhibition of complexes containing DISC 
by cFLIPL and cFLIPS (Table 1, fig. 3A, reactions br1-br14). 
Firstly, we eliminated slow reactions br12 and br13 according to the method MR1. Next, 
we applied the quasi-steady-state analysis (MR2) to the module and removed quasi-stationary 
intermediates CD95R:CD95L, DISC:pro8, DISC:pro82, DISC:p43/p41 and DISC:cFLIPL. 
Thus, in particular, we got two main reactions instead of br1-br6: fast formation of the DISC 
complex (Table 1, fig. 3B, br1*) and slower activation of caspase-8 in this complex (br2*). 
Further, we noticed that the consumptions of cFLIPL and cFLIPS satisfied the same 
kinetic laws. Therefore, these species could be lumped (MR3) resulting in the reaction br4*: 
cFLIP + 2∙DISC + pro8 → cFLIP:DISC:pro8, 
where cFLIP indicated two isoforms cFLIPL and cFLIPS so that                       . 
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Figure 4 – The original model by Neumann et al. and results of the model reduction 
A. The original model decomposed into modules according to three steps of the CD95 
signaling pathways: activation of caspase-8, pro-apoptotic pathway resulting in caspase-3 
activation and anti-apoptotic pathway regulated by NF-κB. The species retained during the 
model reduction are colored; reactions are represented by solid lines. B. The modular view of 
the model. Activation of caspase-8 and p43-FLIP (product of cFLIPL cleavage) occurs at the 
DISC complex and triggers simultaneous processes of cell death and survival. 
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We approximated the concentration of caspase-6 by the linear function         , 
        (MR4), and merged reactions br7 and br8 of caspases-8 activation induced by 
caspases-3 and mediated by caspases-6 into one reaction br3*: 
pro8 –casp3 → casp8. 
Since the reaction br8 followed the Michaelis-Menten kinetics with the constants     and 
    , then the reaction rate of br3* was provided by the kinetic law 
                      (          )⁄   
where               and          . Analysis of this kinetic law for low level of 
CD95L ensured that           . In addition, in the case of the fast activation scenario the 
value of       was much lower than the rate of caspase-8 activation mediated by CD95. Thus, 
we established                  without significant changes in the results of the model 
simulation (MR1, MR5). 
Complementing the above reduction steps, we removed the elements that were 
unnecessary to fit the experimental dynamics provided by Bentele et al. These elements were 
degradation reactions of CD95L, CD95R and FLIP, and the blocked DISC complex 
(inactivated DISC). As a result, we introduced the conservation law: 
                           
where    and    denote initial concentrations of the ligand and receptor, respectively. 
Solving the differential equation 
       
  
                     
we obtained the analytical function for the receptor concentration: 
       
     
      ⁄     (     (     )   )
 (14) 
The module of caspase-9 activation consisted of 19 species and 14 reactions (besides the 
reactions of degradation) including activation of caspase-9 triggered by cytochrome C, 
cleavage/activation of Bid by caspases-2 and -8, IAP inhibition of caspase-9 activity and 
binding of inhibitors by Smac (br15-br26, br35, br38). Based on the method MR1, we 
eliminated the last two reversible reactions, as well as the slow reaction br20 of the 
apoptosome complex dissociation. Further, since this complex was a quasi-stationary 
intermediate and the rate of br15 was linearly dependent on a difference of br16 and br17 
rates, we reduced the chain of procaspase-9 activation (br15-br20), using the methods MR2 
and MR4, to the form: 
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Cyt C stored → Cyt C:Apaf-1, 
pro9 -Cyt C:Apaf-1 → casp9. 
(15) 
Accordingly to Bentele et al., we have the following rule of cytochrome C release from 
mitochondria: 
                           ( )          ( )  
                
  
  
              
  
 
Here         ( ) satisfies the formula (11). Taking into account (15) and ignoring degradation 
of the complex Cyt C:Apaf-1, we got 
              
  
    
              
  
 
where        was the coefficient of linearity. 
Then, we noticed that the experimental measurements of procaspase-9 concentration were 
presented by Bentele and his colleagues only for 200 ng/ml of anti-CD95. In this case, 
degradation of procaspase-9 was insignificant. Thus, neglecting it and considering the kinetic 
law                           of the second reaction in (15), we obtained the differential 
equation of procaspase-9 dynamics: 
      
  
       (          ( )               ( )             )  
Solving it, we found: 
           ( )  (
        ( )  (   (        )   )   
   (        )
)
                 ( )      
      
  (16) 
Finally, analyzing reactions of Bid activation (br21-br23), we removed the slower reaction 
mediated by caspase-2. The similar reaction involving caspase-8 followed the Michaelis-
Menten kinetics with the constant             . Therefore, we redefined the kinetics of 
this reaction based on the law of mass action (MR5): 
                 ⁄               
The module of PARP inactivation contained 13 species (including the virtual species    ) 
and 11 reactions (excepting reactions of degradation). Six reactions (activation of caspases-3 
and -7 by caspases-8 and -9, and cleavage/inactivation of PARP) were based on the 
Michaelis-Menten kinetics (br27-br32), four reactions reproduced the reversible inhibition of 
caspases-3 and -7 based on the law of mass action (br33, br34, br36, br37), and one 
corresponded to the production of     (br38), simplification of which was discussed above. 
We deleted slow reactions of casp3:IAP and casp7:IAP complexes dissociation and 
ignored slow degradation of procaspase-7 and IAP. Then analyzing the cleavage of 
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procaspases-3 and -7, we eliminated reactions triggered by caspase-9, which were slower in 
comparison to the similar reactions induced by caspase-8. For the same reason we ignored the 
reaction of PARP inactivation by caspase-3 (MR1). 
Considering the remaining reactions with the Michaelis-Menten kinetics (br29, br32), we 
used the following inequalities            and               , which, in 
combination with MR5 and (12), led to the following kinetic laws: 
      
   
    
                    
     
        
               
where                 . 
Thus, the CD95-signaling model consisting of 43 species (including one virtual species), 
80 reactions and 45 kinetic parameters was approximated by a model with 18 species, 26 
reactions and 25 parameters, except the constant concentration of Cytochrome C (fig. 3C). 
Figure 5 shows the comparison of simulated concentrations of these models with 
experimental dynamics obtained by Bentele et al. for the 11 species mentioned above. Since 
this dynamics was expressed in arbitrary units, we uniquely translated it into precise values 
for all proteins with non-zero initial values. However, for such molecules as caspase-8, 
p43/p41, tBid and cPARP, precise values directly depended on the concentration levels at the 
end or in the middle of time series. Accordingly, we computed these levels during the model 
reduction and recalculated experimental dots if necessary. 
Species without experimental evidence (CD95L, DISC, cFLIP, DISC:pro8:cFLIP, IAP, 
caspase-3 and virtual species    ) and reactions br1*-br13* directly affect the simulated 
dynamics of the experimentally measured concentrations (Table 2). Thus, further reduction of 
the model by removing these elements is impossible. Regarding the degradation process, we 
agree with Bentele et al. that experimental data cannot be matched if this process is fully 
ignored. Actually, if we remove any of the retained reactions of degradation, then excepted 
concentration dynamics will be impaired. Thus, we found the minimal complexity 
approximation of the original model.  
Reduction of the CD95-mediated and NF-κB signaling model 
As was mentioned above, Neumann et al. simplified their model in order to reduce the large 
number of free parameters. The authors noted that further simplification of the model was not 
possible because the model fit significantly decreased. However, we removed slow reactions 
(nr4, nr11-nr13, fig. 4A) using the method MR1, and removed the reaction of NF-κB 
degradation (nr23), which was not significant for reproducing the experimental data of the 
original model. Note that we retained the slow reactions nr6 and nr7, the former of which 
regulates apoptosis inhibition in the case of high levels of cFLIPL and procaspase-8 in 
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accordance with the precursor model prediction (see the analysis of the predictions below), 
and the latter of which will be required to combine this model with the Bentele’s model 
hereafter. 
Based on the method MR6, we also took into account the inequality                and 
simplified the kinetic law 
                                   
of the reaction nr19 to the form 
                         ( )             
 
Therefore, we reduced the number of model species from 23 to 20, the number of 
reactions from 23 to 18 and the number of kinetic parameters from 17 to 15 (besides the 
constant concentration of IKK). These modifications did not change the fit to the 
experimental data provided by Neumann et al. (Figure 6). 
Model composition 
Analysis of the reduced models based on the Akaike criterion (7) confirmed that they had 
lower complexity than the original models (table 3). The difference between the mean     
coefficients (8) of the models decreased by 60%, relative to the initial value. In addition, the 
reduced Neumann’s model better approximated experimental data. Therefore, we used it as 
the basis for the model composition. 
We took into account that the considered experimental data were obtained with SKW 6.4 
[18] and HeLa [19] cells, which were shown to behave as type I [21] and type II [28] cells, 
respectively. In this regard, we assumed that: 
(A) initial species concentrations could vary for different cell lines; 
(B) kinetic parameters of all reactions (besides the degradation rate modeled as the 
function       
 ) have the same values for both cell lines, whereas the value of    
could be regulated by various entities and, moreover, is dependent on the initial 
concentration of anti-CD95 [18]; 
(C) type I and type II cells conform to different reaction chains of caspases-3 activation 
[21]. 
We constructed the composite model of CD95 and NF-κB signaling in the following way. 
Firstly, according to the assumption (C), we replaced reaction nr15 in the Neumann’s model 
by a chain of three reactions: 
Bid –casp8 → tBid, 
pro9 –tBid → casp9, 
pro3 –casp9 → casp3. 
(17) 
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Figure 5 – Results of the composite model approximation to the experimental data by 
Bentele et al. 
The experimental data (dots) were obtained by Bentele et al. [18] using Western blot analysis 
and expressed as relative values. Once simulated values (curves in the figure) were found for 
the original Bentele’s model (solid red), the reduced model (dashed black) and the composite 
model (solid blue), experimental points were recalculated taking into account these values. 
Wherever blue or black dots are missing, they coincide with the red dots. Note that 
considering the concentration of procaspase-8 in the original model, we observed 
experimental dynamics for the separate species only, but not for the total amount as expected 
from experiments. Thus, validating parameters of the composite model, we evaluated the 
total amount of procaspase-8. 
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Figure 6 – Comparison of the composite model simulation results with the 
experimental data by Neumann et al. 
The simulated concentrations of the original and reduced models (solid lines), as well as the 
simulated values of the composite model (dashed lines) were obtained by Neumann et al. 
[19] for three different concentrations of anti-CD95: 1500 ng/ml (black), 500 ng/ml (blue), 
and 250 ng/ml (red). We did not recalculate the relative experimental data (dots) as in the 
case of the Bentele’s model due to a slight difference between the results of the composite 
and precursor models. An exception was made for values of procaspase-3 and caspase-3, 
which were normalized for the composite model by the term 0.1 for convenience of the visual 
plots comparison. 
 
 
The first reaction of this chain had the same kinetic law as br7*. The other reactions 
represented br6* and nr15 with kinetics modified using the law of mass action. Such 
modification of br6* was necessary to get the slow increase of caspase-3 concentration 
experimentally described by Neumann et al. [19]. Modification of nr15 consisted in 
substitution of         for        . 
Secondly, we supplemented the Neumann’s model with reaction of caspase-3 inhibition by 
IAP and evaluated parameters in this reaction together with parameters in (17) using the 
corresponding data by Neumann et al. and optimization tools of BioUML [29]. 
Thirdly, we analyzed the changes of the initial concentrations and parameters of the 
derived model required to reproduce the Bentele’s experimental data fixing levels of 
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procaspases-3, -8, cleaved product p43/p41, and caspase-8 (table 4). All the changes, except 
step 4, agreed with assumptions (A) and (B). To reproduce the species dynamics, we had to 
increase the initial concentration of procaspase-3 in the case of HeLa cells by an order of 
magnitude. 
Finally, we combined the modules of caspase-8 and NF-κB activation with the modules of 
caspase-9 activation and PARP inactivation (fig. 7). For this purpose, we modified the last 
two modules based on (17) and refitted their parameters as well as the concentrations 
mentioned in table 4, using experimental data by Bentele et al. For better fit we also 
supplemented the model by degradation reactions of some species (procaspase-9, caspase-9, 
DISC:pro8 and DISC:pro8:FLIPS). 
 
 
Figure 7 – Creation of the composite model 
The modules of caspase-8 and NF-κB activation were taken from the reduced Neumann’s 
model and combined with the modules of caspase-9 activation and PARP inactivation 
isolated from the reduced Bentele’s model. In addition, two last modules were supplemented 
by reactions from the modified module of caspases-3 activation. 
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The resulting composite model (fig. 8) consists of 30 species (including one virtual 
species), 38 reactions (including 15 reactions of the species degradation) and 30 kinetic 
parameters, except for the constant concentration of IKK. The model showed a good fit 
between the simulation results and the experimental data (fig. 5, 6). 
Calculation of the mean     coefficient for this model revealed that it has the same level 
of complexity as the reduced models (Table 3). We also noted that reduction of both models 
did not significantly alter the steady-state concentrations (Tables 5S-6S). However, the 
composite model has different steady-states, which are more stable according to the mean 
sensitivities (9) in the cases of SKW 6.4 cells and HeLa cells stimulated with 250 ng/ml of 
anti-CD95.  
The reduced models are equivalent to the precursor models with respect to their 
biological predictions 
Analyzing the models constructed by Neumann et al. and Bentele et al., we divided 
predictions made by them into two groups: qualitative and quantitative. The first group 
concerned the model network and described mechanisms of the protein-protein interactions. 
It is this group to which we assigned the experimentally validated Neumann's predictions that 
processed caspases are not required for NF-κB activation, as well as that pro-apoptotic and 
NF-κB pathways diverge already at DISC. The corresponding network of reactions was 
preserved in the reduced model. Thus, the prediction remained valid. 
The second group of predictions characterized behavior of the models after changing 
concentrations of some species, such as CD95L, CD95R, procaspase-8, and inhibitors 
cFLIPL, cFLIPS, and IAP. Analyzing the predictions of the models by Neumann et al. and 
Bentele et al. listed in the tables 5 and 6 respectively, we concluded that the reduction of the 
first of them did not alter the species dynamics. For the second reduced model, we detected 
some minor changes in the predictions. However, in general, the model behavior remained in 
a good agreement with the Bentele's experiments. 
Model composition modifies some properties of the precursor models and leads to 
new predictions 
Considering the predictive ability of the composite model, we found that in the case of HeLa 
cells it was completely preserved (table 5). 
In the case of SKW 6.4 cell line, we estimated the value of degradation rate parameter    
based on the experimental observations by Bentele et al. for 1-10 ng/ml of anti-CD95 (table 
6). When performing simulation experiments of the model for this cell line, we used three 
different values of    depending on whether the initial concentration of CD95L was within 
the range 1-100 ng/ml, within the range 100-1000 ng/ml or greater than 1000 ng/ml (table 
3S). 
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Figure 8 – The composite model of the CD95- and NF-κB-signaling 
A. The model integrating pro- and anti-apoptotic machinery described by the models by 
Neumann et al. and Bentele et al. Reactions with the “nr” titles were taken from the first 
model, while the “br” titles indicate reactions from the second one. The “*” symbol marks 
reactions defined in the reduced models. The subscript “m” means that reaction was modified 
for the models composition. B. The modular view of the model. Activation of caspase-8 
triggered by CD95 leads to NF-κB activation and cell survival, on the one hand, and PARP 
cleavage resulted in the cell death, on the other hand. 
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Analyzing the model predictions, we detected differences in the behavior of the Bentele’s 
and the composite models (table 6). The first of them describes a threshold mechanism for 
CD95-induced apoptosis implying that this process is completely stopped when CD95L 
concentration is below the critical value. However, the model predicts a sharp increase of 
cPARP immediately when the level of CD95L exceeds the threshold (table 6, № 1). In 
contrast, the composite model shows a gradual increase of cPARP with increase of the ligand 
level. To determine the apoptotic threshold in this case, we found concentration of CD95L for 
which cPARP ratio is equal to 10% of the initial PARP amount [30]. As in the original 
model, this concentration was in the range of 1-10 ng/ml. Additionally, the models revealed 
sensitivity of the threshold to the concentration of cFLIP (table 6, № 2). Both of them 
predicted the cell death phenotype upon stimulation by 1 ng/ml anti-CD95 and the level of 
cFLIP decreased by ~50%. 
The next prediction, which we observed for SKW 6.4 cells, considers a delay of caspase-8 
activation caused by low concentrations of anti-CD95 (table 6, № 3). The maximal delay 
predicted by the Bentele’s model was about 2500 min, whereas the composite model detected 
a much lower value (700-800 min). Analysis of dependence of caspase-3 concentration on 
initial values of IAP and CD95L (table 6, № 4) also demonstrated differences in the models’ 
predictions. Thus, low level of IAP (less than 1 nM) in the original model results in complete 
cell death. However, under the same condition the composite model shows a smooth increase 
of caspase-3 levels with CD95L changing from 0.3 nM to 1000 nM. If the amount of the 
ligand is less than 0.3 nM, IAP blocks apoptosis completely. In addition, the Bentele’s model 
predicts that high concentration of IAP prevents a significant increase of caspase-3 even for 
high levels of the ligand, whereas in the composite model high concentration of CD95L leads 
to cell death. 
Limitations of the composite model 
We analyzed a set of parametric constraints which allowed us to reduce the precursor models 
(table 10S). Following them, we can recover a detailed description of the investigated 
process. Connection of the composite model with the original model by Neumann et al. was 
preserved, whereas with the original model by Bentele et al. it was partially lost since the 
chains of species interactions were changed for the sake of combining the models together. In 
particular, the pathway of caspase-8 activation in DISC was derived from the Neumann’s 
model as well as the reaction chain of procaspase-9 cleavage was modified. However, 
following the constraints of table 10S, we can complete the composite model with such 
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reactions as Bid truncation by caspase-2 and PARP cleavage triggered by caspase-7. We can 
also recover the details of caspase-9 activation mediated by cytochrome C and Smac release 
from mitochondria but with altered kinetics of release. For now, the question of admissibility 
of such modifications as well as extension of the composite model based on other apoptosis 
models remains open and is a challenge for further research. 
Discussion 
In this paper, we considered two approaches to development of mathematical models of cell 
fate decisions. The first concerns the methodology of model reduction and involves 
approximation of one model by another one of lower dimension without affecting dynamics 
of experimentally measured species. The second implies composition of the models and aims 
at reproducing experimental dynamics of all precursor models. 
There are many advantages of working with low-dimensional models [8]. In particular, the 
researcher has a clear vision of the most important biochemical reactions taking place in the 
modeled system as well as better understanding of them. Low-dimensional models are easier 
to analyze and faster to simulate. This helps to save time and enhances productivity. The 
main limitation of model reduction consists in loss of biological information. However, it 
should be noted that even if some information (for example, about very slow biochemical 
reactions) may be lost, it can result in a more clear understanding of the most important 
interactions and allows focusing on the decisive processes in the model, predictive ability of 
which is reasonably preserved. Hence, this limitation can be transformed into an advantage. 
Model composition aiming at getting a single model from several ones is useful because in 
such a case a computational biologist is able to investigate the composite model behavior 
under different conditions that cannot be performed in the precursor models separately. For 
example, our model allows studying the role of p43-FLIP or IAP in the type I SKW 6.4 or 
type II HeLa cells, respectively, that might become a task for the future work. In other words, 
we constructed the model that describes pro- and anti-apoptotic signal transduction in 
different cell types with reasonable accuracy instead of a couple of different models. 
Whenever necessary, some reaction chains and parameters can be switched off giving 
opportunity to simulate a certain type of cells. In addition, the composite model covers 
experimental data obtained from all precursor models, each of which separately satisfies its 
own data only. 
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Model composition sometimes causes modification of some properties of the initial 
models, resulting in new testable predictions. In our case, such predictions were related to 
SKW 6.4 cells, and some simulation results were different from the corresponding results of 
the original Bentele’s model. Nonetheless, the composite model behavior remained in good 
agreement with experimental data used in modeling by Bentele et al. Thus, the question of 
what model (original or composite) is more realistic requires further experimental 
investigation. 
One of the questions that can be asked concerns the need of reducing models in order to 
combine them. An attempt to construct the composite modular model of apoptosis was made 
in [26]. This attempt revealed multiple conceptual and methodological difficulties. The main 
obvious obstacles included: 
 choice of elements in the overlapping parts of different models; 
 incomparable sets of parameters; 
 the lack of experimental data, as well as inability to use the data obtained for different 
cell lines or in different ways (e.g. single-cell or cell culture measurements); 
 inability to make accurate predictions. 
Model reduction allows solving some of these problems. In particular, reducing the 
number of model elements, we reduce the overlapping parts as well. This may be essential for 
direct combining of models. In addition, the complexity of the reduced model become 
comparable with the complexity of available experimental data. Therefore, the risk of model 
overfitting is decreased. 
In the case when two models are directly related (for example, one model was emerged 
from the other), their composition may be significantly easier in comparison to composition 
of quite different models. In our work, the models by Bentele et al. and Neumann et al. are 
not directly related, as it could be expected as these models were constructed in the same 
research group. For example, they use different reaction chains of caspase-8 activation and 
different values of kinetic parameters in the overlapping reactions. 
Another quite useful principle that we used in modeling was modular structure of the 
developed model. This principle provides flexibility for future extensions. Thus, we are 
planning to extend the composite model and supply it with modules and data from studies of 
TRAIL [31-33] and TNF-α [34, 35] signaling, apoptosome-dependent caspase activation [36] 
and p53 oscillation system [37]. It is noteworthy that the model by Laussmann et al. [33], 
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describing TRAIL-induced activation of caspase-8, emerged from the original study by 
Bentele et al. [18]. This fact may help us in our future work. 
Characterising the models used in our work, we can say that we saved our time working 
with the model by Neumann et al. [19] derived from the BioModels database [27], and spent 
a lot of time to reproduce the model by Bentele et al. [18] that had not existed in a ready-to-
use format. Thus, we would like to emphasize that for the common benefit, the systematic 
application of biological standards in modeling (e.g. SBML [38] and SBGN [39]) and 
depositing the working models in public databases (e.g. BioModels [27]) would significantly 
facilitate analysis of existing biomathematical models and using them as the base for 
development of new composite systems. 
Finally, we believe that the composite model itself may be useful for further investigation 
of apoptosis. 
Conclusions 
Mathematical modeling provides a powerful tool for studying the properties of biological 
processes. Methods of model reduction allowed us to take a first step towards validation of 
the modular model of apoptosis [26]. Using these methods, we composed two models 
describing pathways of CD95- and NF-κB-signaling in one without affecting the fit to the 
experimentally measured dynamics and model predictions. For the model reduction and 
composition, we used the BioUML software that was extended by the required methods of 
analysis. 
The models by Bentele et al. and Neumann et al. reconstructed in BioUML and 
represented using SBML format and SBGN notation, as well as their reduced and 
decomposed versions are available at 
http://ie.biouml.org/bioumlweb/#de=databases/The%20composite%20model%20of%20CD9
5%20and%20NF-kB%20signaling. 
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Tables 
Table 1 – Summary of reactions from the original model by Bentele et al. and the 
reduced model 
Original model Reduced model 
№ Reactions (Kinetics) Rates 
(nM/min)
 
№ Reactions (Kinetics) 
Activation of caspase-8 induced by CD95 
br1 CD95L + CD95R → СD95R:СD95L (MA) 101/100 br1* CD95L → DISC 
(                 , 
       is determined by 
the formula (14)) 
br2 FADD + СD95R:СD95L → DISC (MA) 101/100 
br3 pro8 + DISC → DISC:pro8 (MA) 100/10-1 
br4 pro8 + DISC:pro8 → DISC:pro82 (MA) 10
0
/10
-1
 
br5 DISC:pro82 → DISC:p43/p41 (MA) 10
0
/10
-1
 br2* pro8 –DISC → casp8 
(                      ) br6 DISC:p43/p41 → casp8 + DISC (MA) 10
0
/10
-1
 
Activation of caspase-8 by caspase-3 
br7 pro6 -casp3 → casp6 (M-M) 100/10-1 br3* pro8 –casp3 → casp8 
(          ) br8 pro8 -casp6 → casp8 (M-M) 10
-1
/10
0
 
Inhibition of the DISC complex 
br9 DISC + cFLIPL → DISC:cFLIPL (MA) 101/100 br4* cFLIP + 2∙DISC + pro8 → 
DISC:FLIP:pro8 
(                      ) 
br10 pro8 + DISC:cFLIPL → DISC:cFLIPL:pro8 
(MA) 
10
0
 
br11 DISC + cFLIPS → blocked DISC (MA) 101/100 
br12 DISC:pro8 + cFLIPL → DISC:cFLIPL:pro8 
(MA) 
10
-2
/10
-3
 br5* DISC:FLIP:pro8 → 
p43/p41 
(                     ) br13 DISC:pro8 + cFLIPS → blocked DISC 
(MA) 
10
-2
/10
-3
 
br14 DISC:cFLIPL:pro8 → p43/p41 + blocked 
DISC (MA) 
10
-1
 
Activation of caspase-9 triggered by cytochrome C 
br15 Cyt C stored → Cyt C (        ( )  
             ( )) 
10
2
 br6* pro9 → cleavage 
(the formula (16)) 
br16 Apaf-1 + Cyt C → Cyt C:Apaf-1 (MA) 102 
br17 Cyt C:Apaf-1 → Apaf-1 + Cyt C (MA) 101 
br18 pro9 + Cyt C:Apaf → Apop (MA) 100 
br19 Apop -casp3 → casp9 + Cyt C:Apaf-1 
(M-M) 
10
0
 
br20 Apop → casp9 + Cyt C:Apaf-1 (MA) 10-2 
Activation of Bid 
br21 pro2 –casp3 → casp2 (M-M) 100 br7* Bid –casp8 → tBid 
(
     
      
            ) br22 Bid –casp8 → tBid (M-M) 10
0
 
br23 Bid –casp2 → tBid (M-M) 10-1/100 br8* pro2 –casp3 → cleavage 
(
                
          
) 
Blocking of IAP by Smac 
br24 Smac stored → Smac (        ( )  
            ( )) 
10
2
  
– 
br25 Smac + IAP → IAP:Smac (MA) 10-5 
br26 IAP:Smac → Smac + IAP (MA) 10-5 
Activation of caspases-3 and -7 
br27 pro3 –casp8 → casp3 (M-M) 101/100 br9* pro3 –casp8 → casp3 
 (M-M) br28 pro3 –casp9 → casp3 (M-M) 10-3/100 
br29 pro7 –casp8 → casp7 (M-M) 100/10-1 br10* pro7 –casp8 → cleavage 
(
   
    
             ) br30 pro7 –casp9 → casp7 (M-M) 10
-5
/10
-3
 
PARP inactivation 
br31 PARP -casp3 → cPARP (М-М) 10-1 br11* PARP -casp3 → cPARP 
br32 PARP –casp7 → cPARP (М-М) 100/10-1 
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(
     
        
             ) 
Inhibition of caspases-3, -7 and -9 
br33 casp3 + IAP → casp3:IAP (МA) 100 br12* casp3 + IAP → inhibition 
(MA) br34 casp7 + IAP → casp7:IAP (МA) 10-1 
br35 casp9 + IAP → casp9:IAP (МA) 10-3 
br36 casp3:IAP → casp3 + IAP (МA) 10-2 
br37 casp7:IAP → casp7 + IAP (МA) 10-4/10-3 
br38 casp9:IAP → casp9 + IAP (МA) 10-5/10-4 
Production of the virtual variable     
br39 →    (              (     )⁄  
(                                  
      )) 
10
0
 br13* →     (
                 
        
 
(     )        ) 
Prototypes of parameter notations in the original Bentele’s model are listed in table 1S. 
Abbreviations used in the table represent МA – mass action kinetics and M-M – Michaelis-
Menten kinetics. The column with rates includes rate orders for the fast/reduced activation 
scenarios. 
Table 2 – The role of species and reactions in the apoptotic process described by the 
reduced model 
Species Reactions The role in the apoptosis process 
CD95L br1* Triggering the apoptosis process. 
DISC br2* 
Activation of caspase-8 in the DISC complex. In the case of a high 
ligand concentration, DISC is a slow species, so reactions br1* and 
br2* cannot be combined. 
caspase-3 
br3* 
Activation of caspase-8 via the negative-feedback loop. When the 
concentration of CD95L is reduced, the rate of br3* is an order of 
magnitude higher than the rate of br2*. Thus, activation of caspase-8 
is mainly caused by caspase-3.  
br8* 
Cleavage/activation of procaspase-2 is confirmed by the 
experimental data. 
br9* 
Caspase-3 activation plays a crucial role in the cleavage of 
procaspases-2, -8 and PARP. 
br11* 
PARP inactivation is confirmed by the experimental measurements 
of PARP and cPARP concentrations. 
cFLIP br4* 
Inhibition of the DISC complex. cFLIP blocks the activity of DISC 
preventing a significant increase of caspase-8 concentration. This 
conclusion is consistent with the observations by Bentele et al. 
asserting that down-regulation of cFLIP resulted in cell death 
occurring already upon low concentration of anti-CD95 (1 ng/ml). 
DISC:cFLIP:pro8 br5* 
Production of blocked p43/p41, whose concentration is detected by 
the experimental data. 
 
br6*, br7*, 
br10* 
Activation of Bid and cleavage of procaspases-7 and -9. These 
reactions determine dynamics of the mentioned species in agreement 
with the experimental data. 
IAP br12* 
Inhibition of caspase-3. In the case of the reduced activation 
scenario, IAP prevents caspase-3 from reaching a significant level 
and, therefore, blocks significant increase of caspase-8 due to br3*. 
    br13* The virtual variable     specifies the process of degradation. 
“Experimental data” in this table refers to the data obtained by Bentele et al. [18] 
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Table 3 – Comparison of the investigated models according to Akaike’s information 
criterion (AIC) 
 Bentele et al. Neumann et al. 
Composite 
model 
Original 
model 
Reduced 
model 
Original 
model 
Reduced 
model 
AIC 182.46 138.83 201.58 198.17 318.10 
Mean AIC 1.50 1.14 0.96 0.94 0.96 
Table 4 – Modifications of the reduced Neumann’s model to reproduce the 
experimental data by Bentele et al. 
Step 
Changed 
parameters and 
concentrations 
Initial values, 
modifications 
Reason 
Ranges and 
initial values of 
fitting 
1 CD95R:FADD 
91.266 nM, 
increase 
Case: anti-CD95 = 5 µg/ml 
Procaspase-8 is cleaved in about 30 
minutes. This is possible only if DISC 
concentration reaches a level sufficient 
to accelerate the reaction nr2. 
[10
2
, 10
3
], 
442.821, 
Bentele et al. 
2 procaspase-8 
64.477 nM, 
increase 
Case: anti-CD95 = 5 µg/ml 
The concentration of caspase-8 should 
reach its maxim value in about 20 
minutes. 
[10
2
, 10
3
], 
442.821, 
Bentele et al. 
3 FLIPS 
5.084 nM, 
increase 
Case: anti-CD95 = 200 ng/ml 
As mentioned in table 2, activation of 
caspase-8 is mainly caused by caspase-
3 and, therefore, is delayed 
approximately for 30 minutes. Since 
reactions nr2 and nr5 have the same 
rates, we cannot observe the delay, but 
when we reduce the rate of nr5, we 
can. The latter is achieved by 
upregulation of the DISC:pro8 
complex inhibition. 
[10
1
, 10
2
], 
65.021, 
Bentele et al. 
 
4 k10 
0.121 
nM
-1
min
-1
, 
decrease by 
an order of 
magnitude 
Case: anti-CD95 = 200 ng/ml 
Preventing a rapid growth of caspase-8 
concentration. 
0.012 
5 procaspase-3 
1.443 nM, 
refitting 
Case: anti-CD95 = 5 µg/ml 
Improving approximation of the 
experimental data by Bentele et al. 
[10
0
, 10
1
], 
1.443, 
 Neumann et al. 
6 
Bid, 
procaspase-9 
5.003 nM, 
2.909 nM, 
replacement 
by Bentele’s 
values 
Case: anti-CD95 = 200 ng/ml 
Reproducing the experimental 
dynamics of procaspase-9. 
231.760 (Bid), 
245.101 (pro-9), 
Bentele et al. 
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Table 5 – Analysis of predictions regarding apoptosis in HeLa cells as formulated by 
Neumann et al. 
№ The composite model behavior Predictions by Neumann et al. 
1* 
 
The concentration of anti-CD95 required for the 
apoptosis induction (the apoptotic threshold), is 
within the range of 30-100 ng/ml. This range 
remains the same for CD95 decreased by about 12-
fold. 
 
The simulation time, which we used to reproduce 
this prediction, was 60 hours. 
2* 
 
The decreased receptor number results in 
impairment of both CD95- and NF-κB-signaling 
pathways. To test this prediction, Neumann et al. 
considered levels of caspases-8 cleavage and IκB-α 
degradation for the original (solid lines) amount of 
CD95 and the amount decreased by about 12-fold 
(dashed lines). The concentration of anti-CD95 was 
500 ng/ml. 
3* 
 
Along with increasing the concentration of anti-
CD95 from 500 ng/ml to 1500 ng/ml, p43/p41 peaks 
earlier, while there is almost no difference for p43-
FLIP. 
4 
 
Increased concentrations of cFLIPS inhibit both 
apoptotic and NF-κB pathways, although p43-FLIP 
generation is inhibited at a lower threshold than 
p43/p41 generation. 
5* 
 
Increasing the concentration of cFLIPL leads to a 
steep increase in p43-FLIP generation until it 
reaches a maximum, after which the curve drops. 
Lowered levels of cFLIPL result in very little p43-
FLIP but almost unchanged levels of p43/p41. 
 
At very high concentrations of cFLIPL no p43-FLIP 
is generated. This drop-off was not observed 
experimentally by the authors. 
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6* 
 
Only an intermediate level of cFLIPL promotes NF-
kB activation. Decreased levels of procaspase-8 lead 
to a significantly lower amount of p43-FLIP and, 
subsequently, NF-κB. The figures show of 
logarithmic dependence of the maximal NF-κB 
concentration on the initial values of procaspase-8 
and cFLIPL 
7* 
 
High cFLIPL or low procaspase-8 concentrations 
cause suppression of apoptosis. The figures show 
the same dependence as considered in the previous 
prediction, but with caspases-3 instead of NF-κB. 
All the predictions marked with an asterisk were experimentally tested by Neumann et al. and 
confirmed, unless otherwise noted. The simulation time in predictions 3-7 was 360 min. The 
concentration of anti-CD95 considered by the authors in predictions 4-7 was 1000 ng/ml. 
Table 6 – Predictions of the models for SKW 6.4 cells 
№ The models behavior 
Experimental observations by Bentele et al. and 
predictions of the models 
1 
 
Experiments by Bentele et al.: 
 for 1 ng/ml of anti-CD95, PARP cleavage was not 
observed; 
 the measured death rate for 10 ng/ml of anti-CD95 
was 20-30%. 
Original model (red): 
 the apoptotic threshold is 1.9 ng/ml; 
 cPARP concentration rises dramatically within an 
extremely narrow interval of anti-CD95 levels 
overcoming the apoptotic threshold. 
Composite model (blue): 
 the apoptotic threshold is 3.5 ng/ml; 
 cPARP concentration rises in a smooth manner 
along with the increase of anti-CD95 level. 
2 
 
Experiments by Bentele et al.: down-regulation of 
cFLIP in SKW 6.4 cells by addition of cyclohexamide 
resulted in cell death (40% for 1 day) already upon 1 
ng/ml of anti-CD95. The level of cFLIP was decreased  
to 70%. 
Original (red) and composite (blue) models: 
 the apoptotic threshold is highly sensitive to the 
concentration of cFLIP; 
 decreasing the initial concentration of cFLIP by 
more than 51% and 49% for the original and 
composite models, respectively, leads to cell death 
upon stimulation by 1 ng/ml of anti-CD95. 
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3 
 
Experiments by Bentele et al.: in the 10 ng/ml 
activation scenario, a significant increase of caspase-8 
was observed after more than 4 hours. 
Original (red) and composite (blue) models: anti-
CD95 concentrations which are slightly above the 
apoptotic threshold result in caspase-8 activation after 
a delay of many hours. 
 
The figure shows peak times of caspase-8 
concentration exceeding 0.1% of the initial 
procaspase-8 level. 
4 
 
Original model: 
 low concentrations of IAP (less than 1 nM) result 
in complete cell death; 
 high concentrations of IAP prevent a significant 
increase of caspase-3 even for high concentrations 
of the ligand. 
Composite model: 
 low concentrations of IAP (less than 1 nM) block 
apoptosis for CD95L less than 0.3 nM; 
 high concentrations of CD95L lead to cell death. 
 
The figures show logarithmic dependence of the 
maximal caspases-3 concentration on initial values of 
IAP and CD95L. 
The simulation time was 2880 min (2 days) in all predictions. The apoptotic threshold in the 
prediction 1 is the concentration of anti-CD95 after which cPARP amount exceeds 10% of 
the initial PARP level. 
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Supplementary tables 
Table 1S – Notations of parameters used in the paper and in the original models 
Parameters notation in the paper Parameters notation by Bentele et al., 2004 
              
                   
            
                      
                    
                       
                          
                             
         
              
              
                    
              
              
              
                                
                             
                   
                           
                 
                
                 
                                 
                
                
                
                    
                  
                   
  
Parameters notation in the paper Parameters notation by Neumann et al., 2004 
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Table 2S – Table of all reactions (excepting degradation) and rate constants in the composite model 
№ Reactions Kinetic laws 
Rate constants 
(nM
-1
min
-1
; min
-1
) 
Comments
1
 
nr1 CD95L + CD95R:FADD → DISC                         , Neumann et al., 2010 
nr2 pro8 + DISC → DISC:pro8                               , Neumann et al., 2010 
nr3 DISC + FLIPL → DISC:FLIPL                              , Neumann et al., 2010 
nr5 DISC:pro8 + pro8 → 2 x p43p41                                     , Neumann et al., 2010 
nr6 DISC:pro8 + FLIPL → p43-FLIP                                     , Neumann et al., 2010 
nr7 DISC:pro8 + FLIPS → DISC:pro8:FLIPS                                   , Neumann et al., 2010 
nr8 DISC:FLIPL + pro8 → p43FLIP                                     , Neumann et al., 2010 
nr9 DISC:FLIPL + FLIPL → DISC:FLIPL2                                    , Neumann et al., 2010 
nr10 DISC:FLIPL + FLIPS → DISC:FLIPL:FLIPS                                    , Neumann et al., 2010 
nr14 2 x p43p41 → casp8            
                , Neumann et al., 2010 
nr15_m pro3 –casp9→ casp3                              Fitted value, 
              , Neumann et al., 2010 
nr16 pro8 -casp3→ p43p41                              Fitted value, 
             , Neumann et al., 2010 
nr19 p43FLIP → p43-FLIP:IKK*                                   , 
              
   ,     ( ), Neumann et al., 2010 
nr20 NF-κB:IκB -p43-FLIP:IKK→ NF-κB:IκB-P         κ   κ                             , Neumann et al., 2010 
nr21 NF-κB:IκB-P → NF-κB*                              , Neumann et al., 2010 
br6*_m pro9 -tBid→ casp9                            – 
br7* Bid -casp8→ tBid                           Fitted value, 
           ⁄             
the reduced Bentele’s model 
br8* pro2 -casp3→ (cleavage)                 
          
 
               , 
                 
Fitted values, 
           ,            , 
Bentele et al., 2004 
br9* pro3 -casp8→ casp3                 
          
  
        (HeLa) or 
        (SKW 6.4),  
                
Fitted values, 
           ,                  , 
Bentele et al., 2004 
br10* pro7 -casp8→ (cleavage)                               Fitted value, 
       ⁄           the reduced Bentele’s model 
br11* PARP –casp3→ cPARP                               Fitted value, 
                  ⁄           
the reduced Bentele’s model 
br12* casp3 + IAP → (inhibition)                       Fitted value, 
                     
  , Bentele et al., 2004 
br13* -casp3→ Apoptotic activity      (       )                       Fitted value, 
(                 )         ⁄           
Bentele et al., 2004 
  
                                                     
1
 The column contains basic parameters or expressions (and their values if they were refitted) in the combined models. 
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Table 3S – Table of degraded species and kinetic laws of degradation in the composite model 
Degraded species Degradation rates Rate constants (min
-1
) 
pro2, pro3, pro8, DISC:pro8, DISC:pro8:FLIPS, pro9, Bid, 
PARP 
              
  
     {
               
                                 ⁄  
                                   ⁄  
                           ⁄                ⁄  
 
casp3               
                     , (   , Neumann et al., 2010) 
casp8               
                      , (   , Neumann et al., 2010) 
casp9               
                                 
cPARP                        , (K_DEGRAD_PARP, Bentele et al., 2004) 
tBid                           
p43-FLIP:IKK*                      , (   , Neumann et al., 2010) 
Apoptotic activity (   )                              
Table 4S – Table of nonzero initial concentrations in the composite model 
Species 
Initial concentrations (nM) 
Neumann et al., 2010 
HeLa cells 
Bentele et al., 2004 
SKW 6.4 cells 
Composite model 
HeLa cells 
Composite model 
SKW 6.4 cells 
CD95L                                                               
CD95R –                  – – 
CD95R:FADD                                         
procaspase-2 –                                                      
procaspase-3                                                      
procaspase-7 –                                                    
procaspase-8                                                      
procaspase-9 –                                                      
FLIPL                                             
FLIPS                                                      
IAP –                                    
Bid –                                                     
IKK          –                   
NF-κB:IκB          –                   
PARP –                                                    
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Table 5S – Steady state analysis of the Bentele’s model and the composite model 
Species 
Steady state values, anti-CD95 = 200 ng/ml Steady state values, anti-CD95 = 5 µg/ml 
Original model Reduced model Composite model Original model Reduced model Composite model 
procaspase-2                                                             
procaspase-3 – – –             
procaspase-7 – – –             
procaspase-8                       
           
(total value) 
              
          
(total value) 
procaspase-9             – – – 
caspase-8                         
p43/p41                   – – – 
Bid – – –                               
tBid – – –                         
PARP                         
cPARP – – –             
Table 6S – Steady state analysis of the Neumann’s model and the composite model 
Species 
Steady state values, 
anti-CD95 = 1500 ng/ml 
Steady state values, 
anti-CD95 = 500 ng/ml 
Steady state values, 
anti-CD95 = 250 ng/ml 
Original 
model 
Reduced 
model 
Composite 
model 
Original 
model 
Reduced 
model 
Composite 
model 
Original 
model 
Reduced 
model 
Composite 
model 
procaspase-8 (total)                                                                                               
p43/p41                                                                                           
caspase-8                                     
procaspase-3                                                                                           
caspase-3                                     
IκB                                                                         
IκB-P                                     
p43-FLIP                                     
Table 7S – Calculation of the mean sensitivity for the investigated apoptosis models 
Cell lines, 
anti-CD95 
concentrations 
The model by Bentele et al. The model by Neumann et al. 
The composite model, 
all parameters 
Original model Reduced 
model 
Original model Reduced 
model All parameters  Retained parameters All parameters  Retained parameters 
SKW 6.4, 5 µg/ml                      – – –         
SKW 6.4, 200 ng/ml                      – – –         
HeLa, 1500 ng/ml – – –                             
HeLa, 500 ng/ml – – –                             
HeLa, 250 ng/ml – – –                             
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Table 8S – Analysis of predictions regarding apoptosis in HeLa cells as formulated by Neumann et al. 
№2 
Behavior of the model by 
Neumann et al. 
Behavior of the reduced model The composite model behavior Predictions by Neumann et al.
3
 
1* 
 
The concentration of anti-CD95 required for the 
apoptosis induction (the apoptotic threshold), is within 
the range of 30-100 ng/ml. This range remains the same 
for CD95 decreased by about 12-fold. 
 
The simulation time, which we used to reproduce this 
prediction, was 60 hours. 
2* 
 
The decreased receptor number results in impairment of 
both CD95- and NF-κB-signaling pathways. To test this 
prediction, Neumann et al. considered levels of 
caspases-8 cleavage and IκB-α degradation for the 
original (solid lines) amount of CD95 and the amount 
decreased by about 12-fold (dashed lines). The 
concentration of anti-CD95 was 500 ng/ml. 
3* 
 
Along with increasing the concentration of anti-CD95 
from 500 ng/ml to 1500 ng/ml, p43/p41 peaks earlier, 
while there is almost no difference for p43-FLIP. 
4 
 
Increased concentrations of cFLIPS inhibit both 
apoptotic and NF-κB pathways, although p43-FLIP 
generation is inhibited at a lower threshold than p43/p41 
generation. 
                                                     
2
 All the predictions marked with an asterisk were experimentally tested by Neumann et al. and confirmed, unless otherwise noted. 
3
 The The simulation time in predictions 3-7 was 360 min. The concentration of anti-CD95 considered by the authors in predictions 4-7 was 1000 ng/ml. 
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Table 8S (continuation) 
№ 
Behavior of the model by 
Neumann et al. 
Behavior of the reduced model The composite model behavior Predictions by Neumann et al. 
5* 
 
Increasing the concentration of cFLIPL leads to a steep 
increase in p43-FLIP generation until it reaches a 
maximum, after which the curve drops. Lowered levels 
of cFLIPL result in very little p43-FLIP but almost 
unchanged levels of p43/p41. 
 
At very high concentrations of cFLIPL no p43-FLIP is 
generated. This drop-off was not observed 
experimentally by the authors. 
6* 
 
Only an intermediate level of cFLIPL promotes NF-kB 
activation. Decreased levels of procaspase-8 lead to a 
significantly lower amount of p43-FLIP and, 
subsequently, NF-κB. The figures show of logarithmic 
dependence of the maximal NF-κB concentration on the 
initial values of procaspase-8 and cFLIPL 
7* 
 
High cFLIPL or low procaspase-8 concentrations cause 
suppression of apoptosis. The figures show the same 
dependence as considered in the previous prediction, but 
with caspases-3 instead of NF-κB. 
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Table 9S – Predictions of the models for SKW 6.4 cells 
№ 
Behavior of the model by 
Bentele et al. 
Behavior of the reduced model The composite model behavior 
Experimental observations by Bentele et al. and 
predictions of the models
4
 
1 
 
Experiments by Bentele et al.: 
 for 1 ng/ml of anti-CD95, PARP cleavage was not 
observed; 
 the measured death rate for 10 ng/ml of anti-CD95 
was 20-30%. 
Original and reduced models: 
 the apoptotic threshold5 is 1.9 and 6.9 ng/ml for the 
original and reduced models, respectively; 
 cPARP concentration rises dramatically within an 
extremely narrow interval of anti-CD95 levels 
overcoming the apoptotic threshold. 
Composite model: 
 the apoptotic threshold is 3.5 ng/ml; 
 cPARP concentration rises in a smooth manner along 
with the increase of anti-CD95 level.  
2 
 
Experiments by Bentele et al.: down-regulation of 
cFLIP in SKW 6.4 cells by addition of cyclohexamide 
resulted in cell death (40% for 1 day) already upon 1 
ng/ml of anti-CD95. The level of cFLIP was decreased to 
70%. 
All models: 
 the apoptotic threshold is highly sensitive to the 
concentration of cFLIP; 
 decreasing the initial concentration of cFLIP by more 
than 51%, 86% and 49% for the original, reduced and 
composite models, respectively, leads to cell death 
upon stimulation by 1 ng/ml of anti-CD95. 
3 
 
Experiments by Bentele et al.: in the 10 ng/ml activation 
scenario, a significant increase of caspase-8 was observed 
after more than 4 hours. 
All models: anti-CD95 concentrations which are slightly 
above the apoptotic threshold result in caspase-8 
activation after a delay of many hours. 
 
The figures show peak times of caspase-8 concentration 
exceeding 0.1% of initial procaspase-8 level. 
  
                                                     
4
 The simulation time was 2880 min (2 days) in all predictions. 
5
 The apoptotic threshold is the concentration of anti-CD95 after which cPARP amount exceeds 10% of the initial PARP level. 
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Table 9S (continuation) 
№ 
Behavior of the model by 
Bentele et al. 
Behavior of the reduced model The composite model behavior 
Experimental observations by Bentele et al. and 
predictions of the models 
4 
 
Original and reduced models: 
 low concentrations of IAP (less than 1 nM) result in 
complete cell death; 
 high concentrations of IAP prevent significant 
increase of caspase-3 even for high concentrations of 
the ligand. 
Composite model: 
 low concentrations of IAP (less than 1 nM) block 
apoptosis for CD95L less than 0.3 nM; 
 high concentrations of CD95L lead to cell death. 
 
The figures show logarithmic dependence of the maximal 
caspases-3 concentration on initial values of IAP and 
CD95L. 
  
46 
 
Table 10S – Parametric constraints of the models by Bentele et al. and Neumann et al. 
№ Parametric constraints of the Bentele’s model6 Corresponding reduction steps 
1                ,         , 
                                        , 
         (     ) 
Simplification of the equation of     production 
2                                 Elimination of quasi-stationary intermediates CD95R:CD95L, DISC:pro8, DISC:pro82 and 
DISC:p43/p41. Removal of slow reactions br12 and br13 
3                ,         Deletion of caspase-6 and procaspase-6 
4            or           Formation of the linear kinetic law of caspase-8 activation triggered by caspase-3 
5            Elimination of the quasi-stationary species DISC:cFLIPL 
6       ( )        ( ), 
reactions br9 and br11 have the same rate constant           . 
Lumping of cFLIPL and cFLIPS 
7 vbr19, vcasp9 degr >> vbr20, vbr35, vbr38 Deletion of slow reactions of apoptosome complex dissociation (br20), caspase-9 inhibition (br35) and 
casp9:IAP dissociation (br38) 
8      (            )       ⁄  Elimination of cytochrome C 
9             Elimination of the quasi-stationary apoptosome complex 
10             Deletion of reaction br23 (Bid truncation) and caspase-2 
11             Replacement of the Michaelis-Menten kinetics in br22 with the mass action kinetics 
12            , 
            
Removal of the reactions of caspase-3 (br28) and caspase-7 (br30) cleavage triggered by caspase-9 
13                  (   )              , 
                 (   )               
Deletion of the slow reactions of casp3:IAP (br36) and casp7:IAP (br37) dissociation 
14                         Taking into account the steps described above, we can get only four reactions involving IAP (br33, br34, 
br25 and br26). At this stage, we can remove reactions br25 and br26, as well as their members Smac and 
IAP:Smac. 
15             Removal of the reaction of PARP cleavage by caspase-3 
16            Replacement of the Michaelis-Menten kinetics in br29 by the mass action kinetics 
17               , 
               ,         
Modification of kinetics of br32 
   
№ Parametric constraints of the Neumann’s model Corresponding reduction steps 
1         ,                     The slow reaction of the DISC binding by FLIPS (nr4) leads to production of a very small amount of 
DISC:FLIPS. Therefore, all reactions involving this complex (nr4, nr11-nr13) can be removed without 
any significant effect on the model dynamics. 
2               Setting the constant value of the IKK concentration 
  
 
 
                                                     
6
We did not analyze the constraints on degradation rates of species. 
